Cloeckaert Axel, Grayon Maggy, Grépinet Olivier
Unité de Pathologie Aviaire et Parasitologie, Institut National de la Recherche Agronomique, 37380 Nouzilly, France.
Vaccine. 2002 Jun 7;20(19-20):2546-50. doi: 10.1016/s0264-410x(02)00159-7.
The live attenuated strain B. melitensis Rev.1 is considered the best vaccine available for the prophylaxis of brucellosis in sheep and goats. The Rev.1 vaccine was obtained in the 1950s by a two-step selection involving firstly streptomycin resistance and dependence and secondly reversion of dependence but keeping streptomycin resistance. Chromosomally acquired streptomycin resistance is frequently due to mutations in the gene encoding the ribosomal protein S12, rpsL. Nucleotide sequencing revealed one mutation in the rpsL gene of vaccine strain Rev.1 compared to that of reference strain 16M leading to an amino acid Pro-to-Leu change at codon position 91 (Pro91Leu). This mutation resulted also in the lack of a NciI restriction site in the gene. PCR-restriction fragment length polymorphism (PCR-RFLP) using NciI applied to a large number of Brucella reference and field strains showed that the mutation detected was specific of vaccine strain Rev.1.
减毒活菌株布鲁氏菌Rev.1被认为是预防绵羊和山羊布鲁氏菌病的最佳可用疫苗。Rev.1疫苗是在20世纪50年代通过两步筛选获得的,第一步是对链霉素产生抗性和依赖性,第二步是依赖性的回复但保持链霉素抗性。染色体获得的链霉素抗性通常是由于编码核糖体蛋白S12(rpsL)的基因突变。核苷酸测序显示,与参考菌株16M相比,疫苗菌株Rev.1的rpsL基因中有一个突变,导致密码子位置91处的氨基酸从脯氨酸变为亮氨酸(Pro91Leu)。该突变还导致该基因中缺乏NciI限制位点。使用NciI的PCR-限制性片段长度多态性(PCR-RFLP)应用于大量布鲁氏菌参考菌株和田间菌株,结果表明检测到的突变是疫苗菌株Rev.1特有的。